1. Home
  2. Labeler Index
  3. Liberty Pharmaceuticals, Inc.
  4. NDC Product Code: 0440-8065 Uristatuti Relief Pak Uti Relief Pak

NDC 0440-8065 Uristatuti Relief Pak Uti Relief Pak

View Dosage, Usage, Ingredients, Routes, UNII

Table of Contents

  1. Product Information
  2. Product Packages
  3. Product Characteristics
  4. What is NDC 0440-8065?
  5. Uristatuti Relief Pak Uti Relief Pak Uses
  6. Active Ingredients UNII Codes
  7. Inactive Ingredients UNII Codes
  8. NDC to RxNorm Crosswalk
  9. Patient Education

Product Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.
NDC Product Code:
0440-8065
Proprietary Name:
Uristatuti Relief Pak Uti Relief Pak
Product Type: [3]
INACTIVATED PRODUCT and EXCLUDED the from NDC Directory
Labeler Name: [5]
Liberty Pharmaceuticals, Inc.
Labeler Code:
0440
Product Label ID:
f6e24576-e90c-451e-b2f8-261b61a00fcc
Start Marketing Date: [9]
04-29-2015
Listing Expiration Date: [11]
12-31-2018
Exclude Flag: [12]
I
Code Navigator:

Product Characteristics

Color(s):
BROWN (C48332)
Shape:
ROUND (C48348)
Size(s):
7 MM
Imprint(s):
U
Score:
1

Code Structure Chart

Product Details

What is NDC 0440-8065?

The NDC code 0440-8065 is assigned by the FDA to the product Uristatuti Relief Pak Uti Relief Pak which is product labeled by Liberty Pharmaceuticals, Inc.. The product's dosage form is . The product is distributed in 4 packages with assigned NDC codes 0440-8065-01 100 tablet in 1 bottle , 0440-8065-05 500 tablet in 1 bottle , 0440-8065-30 30 tablet in 1 bottle , 0440-8065-69 96 tablet in 1 blister pack . This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information and RxNorm crosswalk.

What are the uses for Uristatuti Relief Pak Uti Relief Pak?

Adults and children 12 years of age and over: take 2 tablets 3 times daily with a full glass of water, with or after meals as needed.Children under 12 years of age: consult a doctor.Do not use for more than 2 days (12 tablets) without consulting a doctor

Which are Uristatuti Relief Pak Uti Relief Pak UNII Codes?

The UNII codes for the active ingredients in this product are:

  • PHENAZOPYRIDINE HYDROCHLORIDE (UNII: 0EWG668W17)
  • PHENAZOPYRIDINE (UNII: K2J09EMJ52) (Active Moiety)

Which are Uristatuti Relief Pak Uti Relief Pak Inactive Ingredients UNII Codes?

The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:

What is the NDC to RxNorm Crosswalk for Uristatuti Relief Pak Uti Relief Pak?

RxNorm is a normalized naming system for generic and branded drugs that assigns unique concept identifier(s) known as RxCUIs to NDC products.The NDC to RxNorm Crosswalk for this produdct indicates multiple concept unique identifiers (RXCUIs) are associated with this product:

* Please review the disclaimer below.

Patient Education

Phenazopyridine


Phenazopyridine relieves urinary tract pain, burning, irritation, and discomfort, as well as urgent and frequent urination caused by urinary tract infections, surgery, injury, or examination procedures. However, phenazopyridine is not an antibiotic; it does not cure infections.
[Learn More]


* Please review the disclaimer below.

Product Footnotes

[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.

[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.

[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.

[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".